Скачать или смотреть Redefining Prostate Cancer Staging: PSMA PET in Real-World Practice

At the American Urological Association 2025 Annual Meeting, an expert panel convened to discuss the latest research and clinical advancements in metastatic hormone-sensitive prostate cancer (mHSPC) diagnostics and treatment. Moderated by Murilo De Almeida Luz, MD, Icahn School of Medicine at Mount Sinai, the roundtable consisted of Gordon Brown, DO, Summit Health; Daniel Oberlin, MD, Golden Gate Urology; and Gregory C. McMahon, DO, MidLantic Urology.

In the first segment of the discussion, the panel discusses the evolving role of PSMA PET imaging in staging and managing mHSPC, highlighting insurance barriers, diagnostic uncertainties, and the importance of personalized, biopsy-informed decision-making and genetic testing in treatment planning.